Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Phone972-390-9800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$152.45 million
Profitability
Miscellaneous
Employees570
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable
Atrion (NASDAQ:ATRI) Frequently Asked Questions
What is Atrion's stock symbol?
Atrion trades on the NASDAQ under the ticker symbol "ATRI."
How often does Atrion pay dividends? What is the dividend yield for Atrion?
Atrion announced a quarterly dividend on Monday, August 19th. Shareholders of record on Monday, September 16th will be given a dividend of $1.55 per share on Monday, September 30th. This represents a $6.20 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend is Friday, September 13th. This is a positive change from Atrion's previous quarterly dividend of $1.35. View Atrion's Dividend History.
How were Atrion's earnings last quarter?
Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings results on Wednesday, August, 7th. The medical instruments supplier reported $5.18 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $40.10 million for the quarter. Atrion had a net margin of 23.14% and a return on equity of 16.79%. View Atrion's Earnings History.
When is Atrion's next earnings date?
Has Atrion been receiving favorable news coverage?
Media coverage about ATRI stock has trended negative on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Atrion earned a daily sentiment score of -2.5 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Atrion.
Who are some of Atrion's key competitors?
Some companies that are related to Atrion include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Anika Therapeutics (ANIK), Cerus (CERS), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).
What other stocks do shareholders of Atrion own?
Who are Atrion's key executives?
Atrion's management team includes the folowing people:
- Mr. Emile A. Battat, Exec. Chairman (Age 81)
- Mr. David A. Battat, Pres & CEO (Age 49)
- Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)
Who are Atrion's major shareholders?
Atrion's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (0.72%), Pennsylvania Trust Co (0.56%), Virginia Retirement Systems ET AL (0.10%), Nisa Investment Advisors LLC (0.05%), Envestnet Asset Management Inc. (0.02%) and Zurcher Kantonalbank Zurich Cantonalbank (0.01%). Company insiders that own Atrion stock include Jeffery Strickland and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.
Which major investors are selling Atrion stock?
ATRI stock was sold by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL. Company insiders that have sold Atrion company stock in the last year include Jeffery Strickland and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.
Which major investors are buying Atrion stock?
ATRI stock was purchased by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Boston Trust Walden Corp, Zurcher Kantonalbank Zurich Cantonalbank , Envestnet Asset Management Inc. and Pennsylvania Trust Co. View Insider Buying and Selling for Atrion.
How do I buy shares of Atrion?
Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Atrion's stock price today?
One share of ATRI stock can currently be purchased for approximately $798.30.
How big of a company is Atrion?
What is Atrion's official website?
How can I contact Atrion?
Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]
MarketBeat Community Rating for Atrion (NASDAQ ATRI)
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
